(Press-News.org) CAMBRIDGE, MA -- Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer cells could be a promising target for T-cell therapies and other approaches that attack pancreatic tumors.
Known as cryptic peptides, these molecules are produced from sequences in the genome that were not thought to encode proteins. Such peptides can also be found in some healthy cells, but in this study, the researchers identified about 500 that appear to be found only in pancreatic tumors.
The researchers also showed they could generate T cells targeting those peptides. Those T cells were able to attack pancreatic tumor organoids derived from patient cells, and they significantly slowed down tumor growth in a study of mice.
“Pancreas cancer is one of the most challenging cancers to treat. This study identifies an unexpected vulnerability in pancreas cancer cells that we may be able to exploit therapeutically,” says Tyler Jacks, the David H. Koch Professor of Biology at MIT and a member of the Koch Institute for Integrative Cancer Research.
Jacks and William Freed-Pastor, a physician-scientist in the Hale Family Center for Pancreatic Cancer Research at Dana-Farber Cancer Institute and an assistant professor at Harvard Medical School, are the senior authors of the study, which appears today in Science. Zackery Ely PhD ’22 and Zachary Kulstad, a former research technician at Dana-Farber Cancer Institute and the Koch Institute, are the lead authors of the paper.
Cryptic peptides
Pancreatic cancer has one of the lowest survival rates of any cancer — about 10 percent of patients survive for five years after their diagnosis.
Most pancreatic cancer patients receive a combination of surgery, radiation treatment, and chemotherapy. Immunotherapy treatments such as checkpoint blockade inhibitors, which are designed to help stimulate the body’s own T cells to attack tumor cells, are usually not effective against pancreatic tumors. However, therapies that deploy T cells engineered to attack tumors have shown promise in clinical trials.
These therapies involve programming the T-cell receptor (TCR) of T cells to recognize a specific peptide, or antigen, found on tumor cells. There are many efforts underway to identify the most effective targets, and researchers have found some promising antigens that consist of mutated proteins that often show up when pancreatic cancer genomes are sequenced.
In the new study, the MIT and Dana-Farber team wanted to extend that search into tissue samples from patients with pancreatic cancer, using immunopeptidomics — a strategy that involves extracting the peptides presented on a cell surface and then identifying the peptides using mass spectrometry.
Using tumor samples from about a dozen patients, the researchers created organoids — three-dimensional growths that partially replicate the structure of the pancreas. The immunopeptidomics analysis, which was led by Jennifer Abelin and Steven Carr at the Broad Institute, found that the majority of novel antigens found in the tumor organoids were cryptic antigens. Cryptic peptides have been seen in other types of tumors, but this is the first time they have been found in pancreatic tumors.
Each tumor expressed an average of about 250 cryptic peptides, and in total, the researchers identified about 1,700 cryptic peptides.
“Once we started getting the data back, it just became clear that this was by far the most abundant novel class of antigens, and so that’s what we wound up focusing on,” Ely says.
The researchers then performed an analysis of healthy tissues to see if any of these cryptic peptides were found in normal cells. They found that about two-thirds of them were also found in at least one type of healthy tissue, leaving about 500 that appeared to be restricted to pancreatic cancer cells.
“Those are the ones that we think could be very good targets for future immunotherapies,” Freed-Pastor says.
Programmed T cells
To test whether these antigens might hold potential as targets for T-cell-based treatments, the researchers exposed about 30 of the cancer-specific antigens to immature T cells and found that 12 of them could generate large populations of T cells targeting those antigens.
The researchers then engineered a new population of T cells to express those T-cell receptors. These engineered T cells were able to destroy organoids grown from patient-derived pancreatic tumor cells. Additionally, when the researchers implanted the organoids into mice and then treated them with the engineered T cells, tumor growth was significantly slowed.
This is the first time that anyone has demonstrated the use of T cells targeting cryptic peptides to kill pancreatic tumor cells. Even though the tumors were not completely eradicated, the results are promising, and it is possible that the T-cells’ killing power could be strengthened in future work, the researchers say.
Freed-Pastor’s lab is also beginning to work on a vaccine targeting some of the cryptic antigens, which could help stimulate patients’ T cells to attack tumors expressing those antigens. Such a vaccine could include a collection of the antigens identified in this study, including those frequently found in multiple patients.
This study could also help researchers in designing other types of therapy, such as T cell engagers — antibodies that bind an antigen on one side and T cells on the other, which allows them to redirect any T cell to kill tumor cells.
Any potential vaccine or T cell therapy is likely a few years away from being tested in patients, the researchers say.
###
The research was funded in part by the Hale Family Center for Pancreatic Cancer Research, the Lustgarten Foundation, Stand Up To Cancer, the Pancreatic Cancer Action Network, the Burroughs Wellcome Fund, a Conquer Cancer Young Investigator Award, the National Institutes of Health, and the National Cancer Institute.
END
Biologists identify targets for new pancreatic cancer treatments
Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.
2025-05-08
ELSE PRESS RELEASES FROM THIS DATE:
Simple tweaks to a gene underlie the stench of rotten-smelling flowers
2025-05-08
Some plants lure pollinators not with sweet fragrances, but with the rank stench of decay. In a new study, researchers show how plants pull this off. In Asarum flowers, a gene typically used for detoxifying smelly compounds has instead evolved to produce unpleasant odors, the researchers report. The findings shed light on how plants co-opt widely conserved metabolic pathways for ecological advantage. A key feature of foul-smelling flowers is the release of malodorous volatile compounds, particularly oligosulfides like dimethyl disulfide (DMDS) and dimethyl trisulfide (DMTS). These compounds mimic the chemical signals given off by decaying material. ...
Simple, effective interventions reduce emissions from Bangladesh’s informal brick kilns
2025-05-08
Simple and inexpensive interventions aimed at making changes in how Bangladesh’s informal brink kilns operate could dramatically cut emissions and boost profits for producers, according to a new study. The findings may offer a scalable model for tackling pollution in hard-to-regulate informal industries, particularly in low- and middle-income countries (LMICs). In many LMICs, weak regulatory systems limit the effectiveness of pollution control, especially in informal industries that tend to operate outside formal governance and ...
Ultrasound-guided 3D bioprinting enables deep-tissue implant fabrication in vivo
2025-05-08
A new ultrasound-guided 3D printing technique could make it possible to fabricate medical implants in vivo and deliver tailored therapies to tissues deep inside the body – all without invasive surgery, researchers report. 3D bioprinting technologies offer significant promise to modern medicine by enabling the creation of customized implants, intricate medical devices, and engineered tissues tailored to individual patients. However, most current approaches require invasive surgical implantation. Although in vivo bioprinting – “3D printing” tissue directly within the body – offers ...
Soft limbs of flexible tubes and air enable dynamic, autonomous robotic locomotion
2025-05-08
Using only airflow and simple physical design – resulting in a structure that looks like a roadside “inflatable tube dancer” – researchers have developed soft robots that achieve coordinated, autonomous movement without relying on complex electronic controllers. In nature, animals often move with remarkable efficiency. They do this by seamlessly integrating the nervous system, body mechanics, and environmental interactions. This decentralized coordination allows animals to move efficiently without relying on constant direction from the brain. In contrast, most robots depend ...
Researchers develop practical solution to reduce emissions and improve air quality from brick manufacturing in Bangladesh
2025-05-08
Brick manufacturing is a central component of the economy in South Asia, but also a major source of greenhouse gas emissions and air pollution, as the practice releases carbon dioxide (CO₂), fine particulate matter (PM2.5), and other contaminants into the environment. This coal-powered industry poses a serious threat to human health, agriculture, and the environment in low- and middle-income countries that lack the capacity to monitor and regulate these largely informal operations.
As scientists continue to sound the alarm on the increasing dangers of fossil fuels, a new study by researchers at Boston University School of Public Health (BUSPH), Stanford ...
Durham University scientists solve 500-million-year fossil mystery
2025-05-08
-With images-
A peculiar spiny fossil, once thought to represent one of the earliest molluscs, has now been conclusively reclassified by scientists from Durham University and Yunnan University as something entirely different – a distant relative of sponge-like creatures known as chancelloriids.
This striking revelation is set to reshape our understanding of early animal evolution.
The fossil, named Shishania aculeata, hails from 500-million-year-old Cambrian deposits in Yunnan Province, southern China, ...
Red alert for our closest relatives
2025-05-08
New report shows drastic decline in endangered primates and calls for conservation measures
An international team of primate researchers has published the 25 most endangered primate species in Asia, Africa, Madagascar and South America for the years 2023 to 2025. The publication, supported by the German Primate Center (DPZ) - Leibniz Institute for Primate Research in Göttingen, emphasizes how urgently global conservation measures need to be implemented now to save irreplaceable biodiversity.
"The situation is dramatic. If we don't act now, we will lose some of these species forever," warns Christian Roos, geneticist at the German Primate Center. “But ...
3D printing in vivo using sound
2025-05-08
Imagine if doctors could precisely print miniature capsules capable of delivering cells needed for tissue repair exactly where they are needed inside a beating heart. A team of scientists led by Caltech has taken a significant step toward that ultimate goal, having developed a method for 3D printing polymers at specific locations deep within living animals. The technique relies on sound for localization and has already been used to print polymer capsules for selective drug delivery as well as glue-like polymers to seal internal wounds.
Previously, scientists have used infrared light ...
Global Virus Network meeting unites Caribbean and Latin America to tackle emerging viral threats
2025-05-08
KINGSTON, JAMAICA – May 8, 2025 – The Global Virus Network (GVN), in partnership with The University of the West Indies (UWI) Mona Campus and the State University of New York (SUNY) at the University of Buffalo, convened top virologists, epidemiologists, public health experts, and government officials for the 2025 GVN Regional Meeting: Caribbean and Latin America in Kingston, Jamaica held May 1-2, 2025. The two-day summit focused on collaborative strategies to bolster viral surveillance, diagnostics, vaccine research, and pandemic preparedness ...
MD Anderson Research Highlights for May 8, 2025
2025-05-08
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Comprehensive spatial map provides insights into pancreatic cancer metastases
Read summary | Read in Nature
Pancreatic cancer is notoriously difficult to treat, resulting in a five-year survival rate of roughly 12%. Approximately half of patients develop metastases shortly ...
LAST 30 PRESS RELEASES:
Health care workers, firefighters have increased PFAS levels, study finds
Turning light into usable energy
Important step towards improving diagnosis and treatment of brain metastases
Maternal cardiometabolic health during pregnancy associated with higher blood pressure in children, NIH study finds
Mercury levels in the atmosphere have decreased throughout the 21st century
This soft robot “thinks” with its legs
Biologists identify targets for new pancreatic cancer treatments
Simple tweaks to a gene underlie the stench of rotten-smelling flowers
Simple, effective interventions reduce emissions from Bangladesh’s informal brick kilns
Ultrasound-guided 3D bioprinting enables deep-tissue implant fabrication in vivo
Soft limbs of flexible tubes and air enable dynamic, autonomous robotic locomotion
Researchers develop practical solution to reduce emissions and improve air quality from brick manufacturing in Bangladesh
Durham University scientists solve 500-million-year fossil mystery
Red alert for our closest relatives
3D printing in vivo using sound
Global Virus Network meeting unites Caribbean and Latin America to tackle emerging viral threats
MD Anderson Research Highlights for May 8, 2025
Study of Türkiye gold mine landslide highlights need for future monitoring
Researchers find new defense against hard-to-treat plant diseases
Characterization of research grant terminations at the National Institutes of Health
New study: high efficiency of severe thalassemia prevention with HTS based carrier screening
AI-designed DNA controls genes in healthy mammalian cells for first time
Veterans with depression have increased risk of heart failure: Study
Maternal cardiometabolic risk factors in pregnancy and offspring blood pressure at ages 2 to 18
Depression and heart failure in US veterans
Experiences of care and gaslighting in patients with vulvovaginal disorders
Vitamin supplements slow down the progression of glaucoma
Physics: Eggs less likely to crack when dropped side-on
Study links maternal health risks during pregnancy to higher blood pressure in children
Building vaccines for future versions of a virus
[Press-News.org] Biologists identify targets for new pancreatic cancer treatmentsTheir study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.